Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Xcelris Genomics is an India-based genomics research and genetic testing company that provides sequencing, bioinformatics, oligonucleotide synthesis, proteomics, and molecular biology products and services. The business appears to operate through Xcelris Labs Limited and offers next-generation sequencing, Sanger sequencing, oligo synthesis and purification, and related research support for customers in human health, agriculture, animal science, microbial, and environmental genetics. The company also provides medical genetics and diagnostic testing services for areas such as cancer, hereditary disorders, infectious diseases, and cardiology-related conditions. Rather than a drug developer, Xcelris functions primarily as a commercial genomics services and testing organization serving industry, academic, research institute, and individual investigator customers.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Xcelris Genomics.